Search results
This guidance also addresses the new problem of DKA and particularly euglycaemic DKA in those treated with SGLT-2 inhibitors. It also for the first time considers ketosis prone type 2 diabetes and the complex issue of the management of DKA in people with end stage renal failure or on dialysis.
- Dka
For severe acidosis (e.g., bicarbonate <5 mM), consider a 10...
- Dka
6 sie 2021 · For severe acidosis (e.g., bicarbonate <5 mM), consider a 10 unit IV insulin bolus followed by an infusion at 0.2 U/kg/hr. Continue insulin infusion per protocol, until ALL the following criteria are met: Resolution of ketoacidosis (anion gap <10-12 mM, in the absence of renal failure). Bicarbonate >18 mM.
27 kwi 2023 · Management of DKA requires reversing metabolic derangements by correcting volume depletion and electrolyte imbalances and administering insulin to correct acidosis while concurrently treating the precipitating illness [1].
1 lis 2023 · Selected DKA patients may be safely treated outside of the ICU setting. •. Pregnancy, older age, heart, and renal disease require a more tailored approach. Abstract. Diabetic ketoacidosis (DKA) is an acute life-threatening emergency in patients with diabetes, it can result in serious morbidity and mortality.
8 sie 2022 · Kaiser Permanente SRO has had a continuous insulin infusion protocol since 2014 for mild-to-moderate DKA on Med Surg/observation, whereas SRF has managed these patients in the ICU. This study was approved by the KPNC Institutional Review Board with a waiver of informed consent.
Patients with severe DKA (plasma glucose >250 mg/dL, arterial pH <7.00, serum bicarbonate <10 mEq/L), hypotension, anasarca (severe generalized edema), or associated severe critical illness should be managed with intravenous regular insulin in the ICU using the regimen described above.
The guideline takes into account new evidence on the use of the previous version of this document, particularly the high prevalence of hypoglycaemia and hypokalaemia, and recommends that when the glucose concentration drops below 14 mmol/L, that de- escalating the insulin infusion rate from 0.1 to 0.05 units/kg/h should be considered.
